Skip to main content

and
  1. No Access

    Article

    Overall Survival Benefit with Sacituzumab Govitecan in Metastatic Breast Cancer: A Post Hoc Interaction Analyses of a Randomized Controlled Trail

    Yu-Wei Qiao, Guo Yu, Guo-Fu Li in Clinical Drug Investigation (2024)

  2. No Access

    Article

    Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate

    **ang Chen, Guo Yu, Guo-Fu Li in European Journal of Drug Metabolism and Pharmacokinetics (2023)

  3. Article

    Non-peer-reviewed data, effect measures, and meta-regression analysis on proton pump inhibitor use and COVID-19

    Dan-Na Wu, Li-Rong Jiao, Guo-Fu Li, Guo Yu in European Journal of Clinical Pharmacology (2022)

  4. No Access

    Article

    Prediction of Non-Linear Pharmacokinetics of Monoclonal Antibodies in Human from Nonclinical Data: Are We There Yet?

    Yichao Yu, Qi-Qi Zhao in European Journal of Drug Metabolism and Pharmacokinetics (2021)

  5. No Access

    Article

    Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis

    Cytochrome P450 (CYP) enzymes are one of the main sources of variability in drug metabolic clearance. Information on their abundance levels is therefore crucial to optimize scaling factors for in vitro–in vivo...

    **ao-**ao An, Yichao Yu, Guo-Fu Li, Guo Yu in European Journal of Drug Metabolism and Ph… (2021)

  6. Article

    Open Access

    Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is a common tumor characterized by high morbidity and mortality rates. The importance of circRNA in cancer diagnosis has been established. The study aimed to identify differentia...

    **ang-Hong Sun, Yu-Tong Wang, Guo-Fu Li, Nan Zhang, Ling Fan in Cancer Cell International (2020)

  7. No Access

    Article

    How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective

    Delayed or missed doses are unavoidable in clinical practice and remain as a challenge that threatens a patient’s health and quality-of-life, especially in the pharmacotherapy of chronic disease treatment. Unf...

    Jia-qin Gu, Yun-peng Guo, Zheng Jiao in European Journal of Drug Metabolism and Ph… (2020)

  8. No Access

    Article

    Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective

    Guo Yu, Guo-Fu Li in European Journal of Drug Metabolism and Pharmacokinetics (2020)

  9. No Access

    Article

    Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults

    The vast majority of physiological and biological data required for physiologically based predictions are primarily available in Caucasians rather than other ethnic populations, which leads to a lack of confid...

    Guo-Fu Li, Qing-Shan Zheng, Yichao Yu, Wei Zhong in Clinical Pharmacokinetics (2019)

  10. No Access

    Article

    Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese

    Prospective prediction of pharmacokinetic properties for individuals of different ethnic groups could provide useful information for the design of multiregional clinical trials. The accuracy of interethnic sca...

    Guo Yu, Hong-Hao Zhou, Qing-Shan Zheng in European Journal of Clinical Pharmacology (2019)

  11. Article

    Model-Informed Approaches for Alternative Aripiprazole Dosing Regimens and Missed Dose Management: Towards Better Adherence to Antipsychotic Pharmacotherapy

    Jun-Yi Wu, Guo Yu, Guo-Fu Li in European Journal of Drug Metabolism and Pharmacokinetics (2018)

  12. No Access

    Article

    Conflicting meal recommendations for oral oncology drugs: pose risks to patient care?

    The labeling information, authorized by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is expected to guide the method of drug administration with reference to meal intake, ...

    Guo Yu, Dan-Na Wu, Yan Gong, Guo-Fu Li in European Journal of Clinical Pharmacology (2018)

  13. No Access

    Article

    Modeling Drug Disposition and Drug–Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective

    Guo-Fu Li, Qing-Shan Zheng in European Journal of Drug Metabolism and Pharmacokinetics (2018)

  14. No Access

    Article

    Comment on: “A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood”

    Guo-Fu Li, **ao Gu, Guo Yu, Shui-Yu Zhao, Qing-Shan Zheng in Clinical Pharmacokinetics (2016)

  15. No Access

    Article

    Similarities and Differences in Gastrointestinal Physiology Between Neonates and Adults: a Physiologically Based Pharmacokinetic Modeling Perspective

    Physiologically based pharmacokinetic (PBPK) modeling holds great promise for anticipating the quantitative changes of pharmacokinetics in pediatric populations relative to adults, which has served as a useful...

    Guo Yu, Qing-Shan Zheng, Guo-Fu Li in The AAPS Journal (2014)

  16. No Access

    Article

    Ethnic-Specific In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Approaches to Predict Cytochrome P450-Mediated Pharmacokinetics in the Chinese Population: Opportunities and Challenges

    Guo-Fu Li, Guo Yu, Hong-**a Liu, Qing-Shan Zheng in Clinical Pharmacokinetics (2014)

  17. Article

    Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling

    To develop and evaluate a whole-body physiologically based pharmacokinetic (WB-PBPK) model of bisoprolol and to simulate its exposure and disposition in healthy adults and patients with renal function impairment.

    Guo-fu Li, Kun Wang, Rui Chen, Hao-ru Zhao, ** Yang in Acta Pharmacologica Sinica (2012)

  18. No Access

    Article

    Dobutamine Enhances Alveolar Fluid Clearance in a Rat Model of Acute Lung Injury

    Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), remain leading factors for morbidity and mortality in critically ill patients. A significant aspect of ALI and ARD...

    **ng-Mao Wu, Hai-Yuan Wang, Guo-Fu Li, Bin Zang, Wei-Min Chen in Lung (2009)

  19. No Access

    Article

    Interaction of Hydrogen Peroxide with Ribulose-1,5-bisphosphate Carboxylase/Oxygenase from Rice

    The properties of rice-derived ribulose-1,5-bisphosphate carboxylase/oxygenase (rubisco) in different concentrations of hydrogen peroxide (H2O2) solutions have been studied. The results indicate that at low H2O2 ...

    Sen Li, Wei Lu, Guo-Fu Li, Yan-Dao Gong, Nan-Ming Zhao in Biochemistry (Moscow) (2004)

  20. No Access

    Article

    Strong-Light Photoinhibition Treatment Accelerates the Changes of Protein Secondary Structures in Triton-Treated Photosystem I and Photosystem II Complexes

    Changes in the protein secondary structure and electron transport activity of the Triton X-100-treated photosystem I (PSI) and photosystem II (PSII) complexes after strong illumination treatment were studied u...

    **ang Ruan, Qiang Xu, Hai-bin Mao, Guo-fu Li, Jie Wei in Journal of Protein Chemistry (2001)